| Compound Information | |
|---|---|
| ID | 44 |
| TrivialName | Gypenoside XVII |
| Type | PPD |
| MF | C₄₈H₈₂O₁₈ |
| MolecularWeight | 947.166 |
| IUPACName | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol |
| m/z | 991.5464 |
| Retention Time | 43.68 |
| CCS | 322.07 |
| Adducts | [M−H+HCOOH]− |
| Isomeric SMILES | CC1(C)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]3(C)C1CC[C@]4(C)C3C[C@@H](O)C5[C@@]4(C)CCC5[C@@](C)(O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]7[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O7)O6)CC/C=C(C)/C |
| Canonical SMILES | CC(C)=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
| Source | PpGh |
| Functions | Anti-apoptotic, Anti-inflammatory, Alleviates atherosclerosis, Neuroprotective effects, Treatment of Diabetic retinopathy, Cardioprotective |
| Year | 1985 |
| References | |
| Structure |
|